Article info

Combined high-dose platinum and etoposide in previously untreated ovarian cancer patients with residual disease

Authors

  • G. Strauss Department of Oncology, Rigshospitalet, University Hospital of Copenhagen; †Department of Internal Medicine F, Hillerød Hospital, Hillerød; ‡Department of Internal Medicine P, Bispebjerg Hospital, University Hospital of Copenhagen, Denmark PubMed articlesGoogle scholar articles
  • B. Lund Department of Oncology, Rigshospitalet, University Hospital of Copenhagen; †Department of Internal Medicine F, Hillerød Hospital, Hillerød; ‡Department of Internal Medicine P, Bispebjerg Hospital, University Hospital of Copenhagen, Denmark PubMed articlesGoogle scholar articles
  • M. Hansen Department of Oncology, Rigshospitalet, University Hospital of Copenhagen; †Department of Internal Medicine F, Hillerød Hospital, Hillerød; ‡Department of Internal Medicine P, Bispebjerg Hospital, University Hospital of Copenhagen, Denmark PubMed articlesGoogle scholar articles
  • O. P. Hansen Department of Oncology, Rigshospitalet, University Hospital of Copenhagen; †Department of Internal Medicine F, Hillerød Hospital, Hillerød; ‡Department of Internal Medicine P, Bispebjerg Hospital, University Hospital of Copenhagen, Denmark PubMed articlesGoogle scholar articles
  • H.H. Hansen Department of Oncology, Rigshospitalet, University Hospital of Copenhagen; †Department of Internal Medicine F, Hillerød Hospital, Hillerød; ‡Department of Internal Medicine P, Bispebjerg Hospital, University Hospital of Copenhagen, Denmark PubMed articlesGoogle scholar articles
  1. Address for correspondence: Dr G. Strauss, Department of Oncology 5072, Rigshospitalet, Blegdamsvej 9, DK-2100, Denmark.

Citation

Strauss G, Lund B, Hansen M, et al
Combined high-dose platinum and etoposide in previously untreated ovarian cancer patients with residual disease

Publication history

  • First published September 1, 1996.
Online issue publication 
December 03, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.